GeneDx Holdings (WGS) Capital Leases (2020 - 2021)

GeneDx Holdings (WGS) posted quarterly Capital Leases of $18.4 million for Q4 2021, down 11.31% YoY from $20.8 million in Q4 2020, and down 11.31% sequentially from $20.8 million in Q4 2020.

GeneDx Holdings (WGS) Capital Leases (2020 - 2021) Analysis & Trends

GeneDx Holdings has disclosed Capital Leases across 2 years of filings, most recently posting $18.4 million for Q4 2021.

  • In Q4 2021, Capital Leases fell 11.31% year-over-year to $18.4 million; the TTM figure through Dec 2021 stood at $18.4 million (down 11.31% YoY), while the FY2021 annual figure was $18.4 million, down 11.31% from the prior year.
  • Capital Leases slipped to $18.4 million in Q4 2021, from $20.8 million in the prior quarter.
  • Over the last five years, Capital Leases for WGS reached as high as $20.8 million in Q4 2020 and fell as low as $18.4 million in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Waters 31,055.11 Bn 31,054.65 Bn 1.11 Bn
2 Thermo Fisher Scientific 191.02 Bn 187.77 Bn 7.74 Bn
3 Danaher 137.16 Bn 131.47 Bn 3.59 Bn
4 Idexx Laboratories 42.82 Bn 42.62 Bn 722.74 Mn
5 Natera 39.09 Bn 37.99 Bn 696.04 Mn
6 Agilent Technologies 37.61 Bn 35.81 Bn 990.00 Mn
7 Iqvia Holdings 34.23 Bn 32.25 Bn 1.36 Bn
8 Illumina 28.14 Bn 26.98 Bn 721.00 Mn
9 Mettler Toledo International 26.40 Bn 26.33 Bn 555.82 Mn
10 GeneDx Holdings 2.10 Bn 1.93 Bn 68.21 Mn

Historic Data

Download Data
DateValue
Dec 31, 2021 18.43 Mn
Dec 31, 2020 20.78 Mn